- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x 3GR: D-Glyceraldehyde(Non-covalent)
3GR.2: 5 residues within 4Å:- Chain A: R.318, N.344, S.345, H.416, R.474
7 PLIP interactions:5 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:R.318, A:R.318, A:N.344, A:H.416, A:R.474
- Water bridges: B:K.260, B:K.260
3GR.16: 4 residues within 4Å:- Chain B: R.318, S.345, H.416, R.474
8 PLIP interactions:6 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:R.318, B:R.318, B:N.344, B:R.474
- Water bridges: B:H.416, B:D.424, A:K.260, A:K.260
- 2 x THD: 2-[3-[(4-AMINO-2-METHYL-5-PYRIMIDINYL)METHYL]-2-(1,2-DIHYDROXYETHYL)-4-METHYL-1,3-THIAZOL-3-IUM-5-YL]ETHYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
THD.3: 27 residues within 4Å:- Chain A: H.37, S.40, K.75, H.77, H.110, G.123, S.124, L.125, G.154, D.155, G.156, E.157, E.160, N.185, L.187, G.188, Q.189, K.244, H.258
- Chain B: D.341, T.342, I.364, E.366, F.392, R.395, Q.428
- Ligands: CA.1
19 PLIP interactions:3 interactions with chain B, 16 interactions with chain A- Hydrophobic interactions: B:F.392, A:L.125
- Hydrogen bonds: B:Q.428, A:H.110, A:G.123, A:L.125, A:D.155, A:G.156, A:E.157, A:N.185
- pi-Stacking: B:F.392
- Water bridges: A:H.77, A:N.185
- Salt bridges: A:K.75, A:H.77, A:H.77, A:K.244, A:K.244, A:H.258
THD.17: 27 residues within 4Å:- Chain A: D.341, T.342, I.364, E.366, F.392, R.395, Q.428
- Chain B: H.37, S.40, K.75, H.77, H.110, G.123, S.124, L.125, G.154, D.155, G.156, E.157, E.160, N.185, L.187, G.188, Q.189, K.244, H.258
- Ligands: CA.15
20 PLIP interactions:5 interactions with chain A, 15 interactions with chain B- Hydrophobic interactions: A:T.342, A:F.392
- Hydrogen bonds: A:Q.428, B:H.110, B:G.123, B:L.125, B:D.155, B:G.156, B:E.157, B:N.185, B:N.185
- Water bridges: A:T.388, B:H.77
- pi-Stacking: A:F.392
- Salt bridges: B:K.75, B:H.77, B:H.77, B:K.244, B:K.244, B:H.258
- 25 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 5 residues within 4Å:- Chain A: E.423, K.597
- Chain B: A.33, R.101, K.102
Ligand excluded by PLIPEDO.5: 4 residues within 4Å:- Chain A: Y.564, L.587, A.588, N.590
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain A: F.71, V.72, L.73, L.82, F.117, T.118
Ligand excluded by PLIPEDO.7: 7 residues within 4Å:- Chain A: P.63, N.68, D.69, R.70, F.71, W.86, R.379
Ligand excluded by PLIPEDO.8: 8 residues within 4Å:- Chain A: R.21, S.25, A.84, A.87, E.88, E.94, L.97, K.283
Ligand excluded by PLIPEDO.9: 8 residues within 4Å:- Chain A: L.158, S.159, W.164
- Chain B: W.164, E.165, A.168, F.209
- Ligands: EDO.12
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: L.92, D.106, L.107, Q.115
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: Y.563, Y.564, E.565, V.589, N.590
- Chain B: P.441, K.538
Ligand excluded by PLIPEDO.12: 8 residues within 4Å:- Chain A: L.158, S.159, W.164, L.195, Y.202, R.205
- Chain B: F.209
- Ligands: EDO.9
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain A: Q.189, S.256, W.257, H.258
- Chain B: N.344
Ligand excluded by PLIPEDO.14: 4 residues within 4Å:- Chain A: S.171, I.172
- Chain B: P.194, L.195
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain A: A.33, R.101, K.102
- Chain B: E.423, K.597
Ligand excluded by PLIPEDO.19: 9 residues within 4Å:- Chain A: E.165, A.168, F.169, I.172, C.362, Y.363, A.365
- Chain B: S.159
- Ligands: EDO.24
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain B: F.71, V.72, L.73, L.82, F.117, T.118
Ligand excluded by PLIPEDO.21: 7 residues within 4Å:- Chain B: P.63, N.68, D.69, R.70, F.71, W.86, R.379
Ligand excluded by PLIPEDO.22: 8 residues within 4Å:- Chain B: R.21, S.25, A.84, A.87, E.88, E.94, L.97, K.283
Ligand excluded by PLIPEDO.23: 7 residues within 4Å:- Chain A: F.209
- Chain B: L.158, W.164, L.195, Y.202, R.205
- Ligands: EDO.24
Ligand excluded by PLIPEDO.24: 9 residues within 4Å:- Chain A: W.164, E.165, A.168, F.209
- Chain B: L.158, S.159, W.164
- Ligands: EDO.19, EDO.23
Ligand excluded by PLIPEDO.25: 6 residues within 4Å:- Chain B: Q.127, G.128, A.131, S.371, V.374, Q.399
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain A: N.344
- Chain B: Q.189, S.256, W.257, H.258
Ligand excluded by PLIPEDO.27: 7 residues within 4Å:- Chain A: P.441, K.538
- Chain B: Y.563, Y.564, E.565, V.589, N.590
Ligand excluded by PLIPEDO.28: 4 residues within 4Å:- Chain B: Y.564, L.587, A.588, N.590
Ligand excluded by PLIPEDO.29: 2 residues within 4Å:- Chain B: N.590, R.591
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain B: L.92, D.106, L.107, Q.115
Ligand excluded by PLIPEDO.31: 6 residues within 4Å:- Chain B: P.475, N.477, V.510, E.514, P.598, L.602
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, Z. et al., Multifaceted Role of the Substrate Phosphate Group in Transketolase Catalysis. Acs Catalysis (2024)
- Release Date
- 2024-01-24
- Peptides
- Transketolase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x 3GR: D-Glyceraldehyde(Non-covalent)
- 2 x THD: 2-[3-[(4-AMINO-2-METHYL-5-PYRIMIDINYL)METHYL]-2-(1,2-DIHYDROXYETHYL)-4-METHYL-1,3-THIAZOL-3-IUM-5-YL]ETHYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
- 25 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, Z. et al., Multifaceted Role of the Substrate Phosphate Group in Transketolase Catalysis. Acs Catalysis (2024)
- Release Date
- 2024-01-24
- Peptides
- Transketolase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B